Skip to main content

Pindolol Pregnancy and Breastfeeding Warnings

Brand names: Visken

Medically reviewed by Drugs.com. Last updated on Jul 30, 2025.

Pindolol Pregnancy Warnings

This drug should be used during pregnancy only if the benefit outweighs the risk to the fetus.
-According to some authorities: Use is contraindicated.

AU TGA pregnancy category: C
US FDA pregnancy category: Not assigned

Risk summary: Inadequate data available on the use of this drug in pregnant women to inform a drug-related risk.

Comment:
-Beta adrenergic blocking agents may cause bradycardia in the fetus.

Animal studies exceeding 100 times the maximum recommended human doses, revealed no embryotoxicity or teratogenicity. There are no controlled data in human pregnancy. It is not known whether this drug can cause fetal harm or adversely affect reproductive capacity in humans.

AU TGA pregnancy category C: Drugs which, owing to their pharmacological effects, have caused or may be suspected of causing, harmful effects on the human fetus or neonate without causing malformations. These effects may be reversible. Accompanying texts should be consulted for further details.

US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D, and X are being phased out.

See references

Pindolol Breastfeeding Warnings

Caution is recommended.

Excreted into human milk: Yes

Limited information indicates that this drug is excreted in low levels in maternal milk. It has a short half-life and only moderate renal excretion, so it would not be expected to cause any adverse effects in breastfed infants, especially if the infant is older than 2 months.

See references

Does Pindolol interact with my other drugs?

Enter medications to view a detailed interaction report using our Drug Interaction Checker.

See also

References for pregnancy information

  1. Cerner Multum, Inc. "UK Summary of Product Characteristics."
  2. Cerner Multum, Inc. "Australian Product Information."
  3. (2016) "Product Information. Pindolol (pindolol)." Par Pharmaceutical Inc (formerly Qualitest Pharmaceuticals Inc)
  4. (2022) "Product Information. Pindolol (pindolol)." ANIP Acquisition Company

References for breastfeeding information

  1. Cerner Multum, Inc. "UK Summary of Product Characteristics."
  2. Cerner Multum, Inc. "Australian Product Information."
  3. United States National Library of Medicine (2013) Toxnet. Toxicology Data Network. http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT
  4. (2016) "Product Information. Pindolol (pindolol)." Par Pharmaceutical Inc (formerly Qualitest Pharmaceuticals Inc)

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer